News
RELX
29.29
-0.64%
-0.19
Opportunity in AI-Resilient Software Companies as Market Overly Bearish -- Market Talk
Dow Jones · 11h ago
Zacks Industry Outlook Highlights RELX and Yelp
NASDAQ · 15h ago
2 Internet Content Stocks to Buy From a Prospering Industry
NASDAQ · 1d ago
Weekly Report: what happened at RELX last week (0202-0206)?
Weekly Report · 1d ago
 UK Stocks-Factors to watch on February 9
Reuters · 1d ago
European Software Stocks Continue to Slip -- Market Talk
Dow Jones · 4d ago
London’s FTSE 100 dips as Shell disappoints on earnings; BoE rate call awaited
Reuters · 5d ago
AI Panic or Real Reset? Software Stocks Lose Nearly $1 Trillion as Investors Weigh AI’s Threat
TipRanks · 5d ago
BUZZ-Retail investors buy software dip, shrug off AI fears
Reuters · 6d ago
Software Stocks Are Likely to Face Near-Term Pressure -- Market Talk
Dow Jones · 6d ago
AI Disrupts Software Business Models -- Market Talk
Dow Jones · 6d ago
Here Are the Global IT and Data Stocks Swept Up in the AI Selloff
The Wall Street Journal · 6d ago
AI Fears Trigger Selloff in Data and Legal Stocks
TipRanks · 6d ago
PRESS DIGEST-British Business - February 4
Reuters · 6d ago
LIVE MARKETS-US stocks stumble as tech tumbles
Reuters · 02/03 21:28
Enterprise software stocks tumble as analysts mull growth acceleration amid AI impact
Seeking Alpha · 02/03 17:17
Anthropic’s new AI tools rattle legal and IT stocks
TipRanks · 02/03 17:10
BUZZ-Thomson Reuters slumps amid worries over legal AI disruption
Reuters · 02/03 17:00
LIVE MARKETS-Nasdaq, S&P slump as software stocks drop
Reuters · 02/03 16:58
AI Worries Hit Publishers After Anthropic Releases New Tools
The Wall Street Journal · 02/03 14:52
More
Webull provides a variety of real-time RELX stock news. You can receive the latest news about Relx Plc through multiple platforms. This information may help you make smarter investment decisions.
About RELX
RELX PLC is a United Kingdom-based global provider of information-based analytics and decision tools for professional and business customers. The Company operates in four market segments: Risk; Scientific, Technical & Medical; Legal, and Exhibitions. The Risk segment provides customers with information-based analytics and decision tools that combine public and industry-specific content with advanced technology and algorithms to assist them in evaluating and predicting risk and enhancing operational efficiency. The Scientific, Technical & Medical segment helps researchers and healthcare professionals advance science and improve health outcomes by combining high-quality scientific and medical information. The Legal segment provides legal, regulatory and business information and analytics. The Exhibitions segment combines industry expertise with data and digital tools to help customers connect face-to-face and digitally, learn about markets, source products and complete transactions.